This non-promotional symposium has been organised and funded by Novartis Pharmaceuticals UK Limited and Novartis Pharma AG for healthcare professionals only. Novartis has provided funding for the Zurich Heart House Postgraduate Course in Cardiometabolic Medicine 2025 as part of a sponsorship. Novartis has had no input into the content, organisation, conduct or outputs relating to the Event, except for the Novartis sponsored symposium.